Ashby, Jr. C.R., Paul, M., Gardner E.L., Heidbreider, C.A.,
Hagan, J.J., Middlemiss, D.N. The acute administration of the
selective D3 receptor antagonist SB-277011A blocks the expression
of the conditioned place preference response to heroin in male
rats. Synapse, 48(2003) 154-156.
Macdonald, GJ, Branch, CL, Hadley, MS, Johnson, CN, Nash, DJ,
Smith, AB, Stemp, G, Thewlis, KM, Vong, AKK, Austin, NE Phillip, J,
Winborn, KY, Boyfield, I, Hagan, JJ, Middlemiss, DN, Reavill, C,
Riley, GJ, Watson, JM, Parker, SG, Ashby Jr., CR and Wood, M.
Design and Synthesis of
trans-3-(2-(1-(4-(3-(3-(5-Methyl)-1,2,4-oxadiazolyl))
phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine
(SB-414796) : A Potent and Selective Dopamine D3 Receptor
Antagonist. J. Med Chem (2003) 46:4952-4964.
Patel, J.G., Bartoszyk, G., Edwards, E., Ashby, Jr., C.R. The
highly selective 5-hydroxytryptamine (5-HT)2A receptor antagonist,
EMD 281014, significantly increases swimming and decreases
immobility in male congenital learned helpless rats in the forced
swim test. Synapse (2004) 52:76-78.
Zheng X, Gilbert J, Campos A, Kline N, Ashby Jr CR, Hagan JJ,
Heidbreder CA, Gardner EL. Blockade of the dopamine D3
receptors inhibits stress-induced reinstatement of cocaine-seeking
in rats. Psychopharmacology (2004) 176:47-56.
Heidbreider, C.A., Andreoli, M., Marcon, C., Thanos, P.K., Ashby
Jr., C.R., and Gardner, E.L. Role of dopamine D3 receptors in
the addictive properties of ethanol. Drugs Today (2004)
40:255-265.
Heidbreder, C.A., Gardner, E.L., Xi, Z.X., Hagan, J.J., Thanos,
P.K., Ashby, Jr., C.R. The role of central dopamine D3 receptors in
addiction: a review of pharmacological evidence. Brain
Research Reviews (available online Feb, 5, 2005, e-print ahead of
publication).